Blood News and Research

RSS

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Peregrine Pharmaceuticals, Inc., today announced that a research article titled "A Monoclonal Antibody that Binds Anionic Phospholipids on Tumor Blood Vessels Enhances the Antitumor Effect of Docetaxel on Human Breast Tumors in Mice" was published in the May 15 issue of Cancer Research.

16 May 2005

Vaccine candidate to treat nicotine addiction shows promise

Cytos Biotechnology AG has announced that its vaccine candidate CYT002-NicQb to treat nicotine addiction has achieved proof of efficacy.

16 May 2005

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Final results from the largest international study in the treatment of advanced stomach cancer, also known as gastric cancer, demonstrated that patients who received a Taxotere (docetaxel) Injection Concentrate-based chemotherapy regimen (Taxotere, cisplatin and 5-fluorouracil) had significantly improved overall survival rates compared to patients who received a standard treatment (cisplatin and 5- fluorouracil).

16 May 2005

Molecule found in liver cells could explain a lot about the relationship between diet, lipid levels in blood, and atherosclerosis

A team of researchers at the University of Pennsylvania School of Medicine have made a discovery that a molecule found in liver cells is important in explaining the relationship between diet, lipid levels in blood, and atherosclerosis.

15 May 2005

New drug which quickly dissolves blood clots and returns circulation to normal

Cardiovascular patients now have a greater chance of surviving heart attacks after Chinese scientists developed a new drug which quickly dissolves blood clots and returns circulation to normal.

15 May 2005

Breast cancer hormone drug might help prevent prostate cancer

A hormonal drug used to fight breast cancer might help prevent abnormal prostate growths from turning into cancers.

15 May 2005

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

Patients with a particular type of advanced lung cancer may have a new option based on data presented at the 2005 annual meeting of the American Society of Clinical Oncology showing that combining a drug that cuts off the cancer's blood supply with standard chemotherapy can shrink tumors and extend life.

15 May 2005

High nighttime blood pressure linked to increased blood sugar levels

People whose blood pressure doesn't drop significantly overnight tend to have more cardiovascular problems.

15 May 2005

Tamoxifen study counters hopes that drug might protect the heart

Despite previous studies hinting at tamoxifen's potential benefit for breast cancer survivors' heart health, California researchers have found that the breast cancer drug does not decrease survivors' risk of heart attack.

15 May 2005

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Recent studies of a new anticancer drug show continued response for patients with late-stage kidney cancer. Robert Motzer, MD, attending physician at Memorial Sloan-Kettering Cancer Center (MSKCC), reported a response rate of 40 percent in patients with metastatic (advanced) renal cell (kidney) cancer who received SU11248 in second-line therapy.

15 May 2005

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

New research findings may help physicians determine which women have an increased risk of blood clots when taking tamoxifen for the management of breast cancer, a team led by Dana-Farber Cancer Institute investigators will report at the American Society of Clinical Oncology's annual meeting.

15 May 2005

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Counting the amount of a type of normal cell circulating in the blood of people with cancer could predict whether a tumor progresses or responds to therapy, a new study led by the University of Michigan Comprehensive Cancer Center has found. The finding could give doctors an early indication of whether a treatment will be successful, sparing patients months of an ineffective therapy.

15 May 2005

Herceptin could be used safely for bladder cancer

A targeted drug shown to improve the outcome of certain breast cancer patients may be of use in the treatment of advanced cases of bladder cancer, according to new research led by the University of Michigan Comprehensive Cancer Center.

15 May 2005

Third of NHS hospitals - clinical waste was not being stored safely

Inspectors have found that in a third of NHS hospitals, clinical waste was not being stored safely out of patients' reach, and hospitals are putting patients' lives at risk by not getting rid of clinical waste properly.

12 May 2005

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised

Current guidelines generally recommend the initiation of statin therapy when the estimated 10-year risk of a non-fatal heart attack or coronary death is at least 15-20%.

12 May 2005

New trend in treating heart disease in diabetics - angioplasty using the Cypher Sirolimus-eluting coronary stent

The World Health Organisation has predicted an increase in the worldwide prevalence of diabetes of epidemic proportions . Eighty percent of people with diabetes will die from cardiovascular complications -- stroke and/or coronary heart disease (CHD).

12 May 2005

New study says surgery still the best option for prostate cancer

A study by Swedish researchers has found that men who opt to have cancerous prostates surgically removed, have higher long-term survival rates than those who delay the operation, and the benefits of surgery may be greatest for men under 65.

11 May 2005

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

The often embarrassing, excessive sweating disorder, hyperhidrosis, and its treatment options are gaining greater attention from physicians. This is improving the efficacy of treatment and minimizing its adverse effects, Mayo Clinic authors write in the May issue of Mayo Clinic Proceedings.

11 May 2005

Insulin - possible vaccine against type 1 diabetes

It has taken scientists at the University of Miami's Diabetes Research Institute eight long years of painstaking research, but they believe they have finally pinned down Insulin, the hormone most closely linked to diabetes, to be the cause of the inherited form of the blood sugar disease.

11 May 2005

New predictor for blood transplant success

The success of blood stem cell transplants used to treat diseases such as leukemia, Hodgkin’s lymphoma and aplastic anemia may soon become more predictable, thanks to a discovery made by researchers at the University of British Columbia.

11 May 2005

Blood News and Research

Tarvacin equivalent plus Docetaxel inhibits breast tumor growth by 93%

Vaccine candidate to treat nicotine addiction shows promise

Taxotere shows significant survival benefit in the treatment of advanced gastric cancer

Molecule found in liver cells could explain a lot about the relationship between diet, lipid levels in blood, and atherosclerosis

New drug which quickly dissolves blood clots and returns circulation to normal

Breast cancer hormone drug might help prevent prostate cancer

Bevacizumab plus chemo extends survival beyond one year for large group of advanced lung cancer patients

High nighttime blood pressure linked to increased blood sugar levels

Tamoxifen study counters hopes that drug might protect the heart

New anticancer drug SU11248 shows continued response for patients with late-stage kidney cancer

Research findings help predict risk of blood clots in women receiving tamoxifen therapy for breast cancer

Counting number of endothelial cells in blood may predict cancer treatment's effectiveness

Herceptin could be used safely for bladder cancer

Third of NHS hospitals - clinical waste was not being stored safely

Statin therapy is cost-effective for a wider range of individuals with vascular disease or diabetes than previously recognised

New trend in treating heart disease in diabetics - angioplasty using the Cypher Sirolimus-eluting coronary stent

New study says surgery still the best option for prostate cancer

Broader range of treatments for excessive sweating disorder, Mayo Clinic Proceedings says

Insulin - possible vaccine against type 1 diabetes

New predictor for blood transplant success

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Latest News